129 related articles for article (PubMed ID: 24991361)
1. Rapid expansion of new oncology care delivery payment models: results from a payer survey.
Greenapple R
Am Health Drug Benefits; 2013 Jul; 6(5):249-56. PubMed ID: 24991361
[TBL] [Abstract][Full Text] [Related]
2. Emerging trends in cancer care: health plans' and pharmacy benefit managers' perspectives on changing care models.
Greenapple R
Am Health Drug Benefits; 2012 Jul; 5(4):242-53. PubMed ID: 24991323
[TBL] [Abstract][Full Text] [Related]
3. Early experiences with accountable care in Medicaid: special challenges, big opportunities.
Kocot SL; Dang-Vu C; White R; McClellan M
Popul Health Manag; 2013; 16 Suppl 1():S4-11. PubMed ID: 24070249
[TBL] [Abstract][Full Text] [Related]
4. Unraveling the Complexity in the Design and Implementation of Bundled Payments: A Scoping Review of Key Elements From a Payer's Perspective.
Steenhuis S; Struijs J; Koolman X; Ket J; VAN DER Hijden E
Milbank Q; 2020 Mar; 98(1):197-222. PubMed ID: 31909852
[TBL] [Abstract][Full Text] [Related]
5. Payer perceptions on the use of patient-reported outcomes in oncology decision making.
Oderda G; Brixner D; Biskupiak J; Burgoyne D; Arondekar B; Deal LS; Quek RG; Niyazov A
J Manag Care Spec Pharm; 2022 Feb; 28(2):188-195. PubMed ID: 34806908
[No Abstract] [Full Text] [Related]
6. The evolution of payer management of oncology drugs in the United States between 2017 and 2022.
Runyan A; Yi J; Honcz J
J Manag Care Spec Pharm; 2023 Oct; 29(10):1138-1149. PubMed ID: 37695273
[No Abstract] [Full Text] [Related]
7. Consumer, physician, and payer perspectives on primary care medication management services with a shared resource pharmacists network.
Smith M; Cannon-Breland ML; Spiggle S
Res Social Adm Pharm; 2014; 10(3):539-53. PubMed ID: 24055137
[TBL] [Abstract][Full Text] [Related]
8. Improving Oncology Quality Measurement in Accountable Care: Filling Gaps with Cross-Cutting Measures.
Valuck T; Blaisdell D; Dugan DP; Westrich K; Dubois RW; Miller RS; McClellan M
J Manag Care Spec Pharm; 2017 Feb; 23(2):174-181. PubMed ID: 28125364
[TBL] [Abstract][Full Text] [Related]
9. Emerging lessons from regional and state innovation in value-based payment reform: balancing collaboration and disruptive innovation.
Conrad DA; Grembowski D; Hernandez SE; Lau B; Marcus-Smith M
Milbank Q; 2014 Sep; 92(3):568-623. PubMed ID: 25199900
[TBL] [Abstract][Full Text] [Related]
10. Payer perceptions on the use of economic models in oncology decision making.
Biskupiak J; Oderda G; Brixner D; Burgoyne D; Arondekar B; Niyazov A
J Manag Care Spec Pharm; 2021 Nov; 27(11):1560-1567. PubMed ID: 34714111
[No Abstract] [Full Text] [Related]
11. A Survey of Innovative Reimbursement Models in Spine Care.
Kazberouk A; McGuire K; Landon BE
Spine (Phila Pa 1976); 2016 Feb; 41(4):344-52. PubMed ID: 26555826
[TBL] [Abstract][Full Text] [Related]
12. Community oncology in an era of payment reform.
Cox JV; Ward JC; Hornberger JC; Temel JS; McAneny BL
Am Soc Clin Oncol Educ Book; 2014; ():e447-52. PubMed ID: 24857138
[TBL] [Abstract][Full Text] [Related]
13. Updates to the ASCO Patient-Centered Oncology Payment Model.
Ward JC; Bourbeau B; Chin AL; Page RD; Grubbs SS; Kamin DY; Green SR; Rappaport M
JCO Oncol Pract; 2020 May; 16(5):263-269. PubMed ID: 32302272
[TBL] [Abstract][Full Text] [Related]
14. Current and Future Oncology Management in the United States.
Runyan A; Banks J; Bruni DS
J Manag Care Spec Pharm; 2019 Feb; 25(2):272-281. PubMed ID: 30698085
[TBL] [Abstract][Full Text] [Related]
15. Payer and Developer perspectives on alternative payment models.
Moradian R; Meshesha T; Trusheim M; Barlow JF
Expert Rev Pharmacoecon Outcomes Res; 2024 Feb; 24(2):293-301. PubMed ID: 37883069
[TBL] [Abstract][Full Text] [Related]
16. Design and impact of bundled payment for detox and follow-up care.
Quinn AE; Hodgkin D; Perloff JN; Stewart MT; Brolin M; Lane N; Horgan CM
J Subst Abuse Treat; 2017 Nov; 82():113-121. PubMed ID: 29021109
[TBL] [Abstract][Full Text] [Related]
17. Oncologist Support for Consolidated Payments for Cancer Care Management in the United States.
Narayanan S; Hautamaki E
Am Health Drug Benefits; 2016 Jul; 9(5):280-9. PubMed ID: 27625745
[TBL] [Abstract][Full Text] [Related]
18. The Economics of Provider Payment Reform: Are Accountable Care Organizations the Answer?
Feldman R
J Health Polit Policy Law; 2015 Aug; 40(4):745-60. PubMed ID: 26124297
[TBL] [Abstract][Full Text] [Related]
19. Decision Making on Medical Innovations in a Changing Health Care Environment: Insights from Accountable Care Organizations and Payers on Personalized Medicine and Other Technologies.
Trosman JR; Weldon CB; Douglas MP; Deverka PA; Watkins JB; Phillips KA
Value Health; 2017 Jan; 20(1):40-46. PubMed ID: 28212967
[TBL] [Abstract][Full Text] [Related]
20. The opportunity for health plans to improve quality and reduce costs by embracing primary care medical homes.
Collins S; Piper KB; Owens G
Am Health Drug Benefits; 2013 Jan; 6(1):30-8. PubMed ID: 24991345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
